DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital

Core Points - Diagnos Inc. has engaged Centurion One Capital Corp. as the lead agent for a brokered private placement to raise up to approximately $2,000,000 through the sale of up to 6,666,667 units at an issue price of $0.30 per unit [1] - Each unit consists of one common share and one common share purchase warrant, with the warrant exercisable at $0.40 per share for 18 months [1] - The offering is expected to close around December 3, 2025, subject to necessary approvals [4] Use of Proceeds - The gross proceeds from the offering will be allocated for regulatory affairs, product development, business development, and general corporate purposes [2] Offering Details - The units will be offered via private placement in British Columbia, Alberta, Ontario, Quebec, and the United States under an exemption from registration requirements [3] - Related parties of the company may acquire up to approximately 50% of the offering, which will be considered a related party transaction [5] Company Overview - Diagnos Inc. is a publicly traded Canadian corporation focused on early detection of critical eye-related health issues using Artificial Intelligence to enhance diagnostic accuracy and improve patient outcomes [7]